Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-28 Sale | 2024-04-01 9:31 pm | Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell PRESIDENT AND CEO | 5,141 | $4.6248 | $23,776 | 210,236 (Indirect Direct) | View |
| 2024-03-28 Sale | 2024-04-01 9:30 pm | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER | 1,614 | $4.6151 | $7,449 | 44,775 (Direct) | View |
| 2024-03-28 Sale | 2024-04-01 9:28 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 860 | $4.6495 | $3,999 | 71,908 (Direct) | View |
| 2024-03-28 Sale | 2024-04-01 9:27 pm | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, CHIEF MEDICAL OFFICER | 800 | $4.6475 | $3,718 | 231,409 (Direct) | View |
| 2024-03-25 Sale | 2024-03-27 6:59 pm | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER | 2,475 | $4.67 | $11,558 | 42,212 (Direct) | View |
| 2024-03-25 Sale | 2024-03-27 6:57 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 1,350 | $4.67 | $6,305 | 72,768 (Direct) | View |
| 2024-03-25 Sale | 2024-03-27 6:56 pm | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, CHIEF MEDICAL OFFICER | 1,500 | $4.6667 | $7,000 | 232,209 (Direct) | View |
| 2024-03-25 Sale | 2024-03-27 6:54 pm | Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell PRESIDENT AND CEO | 7,950 | $4.6867 | $37,259 | 208,543 (Indirect Direct) | View |
| 2023-11-15 Purchase | 2023-11-17 4:54 pm | Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 1,227,301 | $5.0924 | $6,249,889 | 548,938 (Direct) | View |
| 2023-11-02 Purchase | 2023-11-03 5:37 pm | Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 783,709 | $3.6 | $2,821,352 | 485,083 (Direct) | View |
| 2023-06-07 Sale | 2023-06-09 4:25 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer | 9,273 | $12.03 | $111,526 | 60,118 (Direct) | View |
| 2023-06-06 Sale | 2023-06-07 4:55 pm | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer | 1,200 | $12.04 | $14,448 | 69,391 (Direct) | View |
| 2022-12-09 Sale | 2022-12-13 4:18 pm | Repare Therapeutics Inc. | RPTX | Jerel Davis Director | 250,000 | $16 | $4,000,000 | 3,315,739 (Indirect Direct) | View |
| 2022-06-13 Purchase | 2022-06-15 6:15 pm | Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 149,161 | $12.73 | $1,898,820 | 412,604 (Direct) | View |
| 2022-06-03 Sale | 2022-06-07 4:37 pm | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 750,000 | $12.25 | $9,188,775 | 1,233,615 (Indirect Direct) | View |
| 2022-06-03 Sale | 2022-06-07 4:36 pm | Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner | 750,000 | $12.25 | $9,188,775 | 1,233,615 (Indirect Direct) | View |
| 2022-06-03 Sale | 2022-06-07 4:32 pm | Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner | 750,000 | $12.25 | $9,188,775 | 1,263,593 (Indirect Direct) | View |
| 2022-06-02 Purchase | 2022-06-06 6:14 pm | Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 1,836,958 | $11.9 | $21,859,329 | 406,436 (Direct) | View |
| 2022-05-18 Purchase | 2022-05-20 6:09 pm | Repare Therapeutics Inc. | RPTX | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner | 420,000 | $8.5 | $3,570,000 | 313,357 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-05 4:15 pm | N/A 2034-02-28 | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, CHIEF FINANCIAL OFFICER | 99,000 | $0 | 129,687 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 9:06 pm | N/A 2034-02-28 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER | 99,000 | $0 | 159,118 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 9:04 pm | N/A 2034-02-28 | Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell PRESIDENT AND CEO | 277,000 | $0 | 456,143 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 9:02 pm | N/A 2034-02-28 | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, CHIEF MEDICAL OFFICER | 99,000 | $0 | 318,709 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 4:19 pm | N/A 2029-05-01 | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 43,746 | $0 | 331,629 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 4:19 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 23,556 | $2.425 | 331,629 (Direct) | View |
| 2023-12-11 Exercise | 2023-12-12 4:19 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 20,190 | $2.062 | 331,629 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:32 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | SCHAFER CAROL Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:30 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | RHOADS ANN D Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:27 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | Morrison Briggs Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:26 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | Molineaux Susan Director | 76,200 | $0 | 76,200 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:25 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | Kulkarni Samarth Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:24 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | Foley Todd Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:22 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | Civik Thomas Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:20 pm | N/A 2033-06-07 | Repare Therapeutics Inc. | RPTX | Bonita David P Director | 27,200 | $0 | 27,200 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 9:46 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Zinda Michael EVP, Chief Scientific Officer | 121,650 | $0 | 167,691 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 9:45 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 145,700 | $0 | 295,213 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 9:44 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Segal Lloyd Mitchell President and CEO | 422,750 | $0 | 523,343 (Direct) | View |
| 2023-01-30 Option Award | 2023-02-01 9:44 pm | N/A 2033-01-29 | Repare Therapeutics Inc. | RPTX | Forte Steve EVP, Chief Financial Officer | 135,580 | $0 | 141,737 (Direct) | View |
| 2022-12-29 Other | 2023-01-03 4:38 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Jerel Davis Director | 468,099 | $0 | 2,823,613 (Indirect) | View |
| 2022-12-20 Exercise | 2022-12-20 8:05 pm | N/A 2029-05-01 | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 48,507 | $0 | 305,179 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-20 8:05 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 51 | $2.425 | 305,179 (Direct) | View |
| 2022-12-20 Exercise | 2022-12-20 8:05 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Koehler Maria EVP, Chief Medical Officer | 48,456 | $2.062 | 305,179 (Direct) | View |
| 2022-06-06 Other | 2022-06-07 4:37 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Vantage I L.P. Versant Vantage I GP L.P. Versant Vantage I GP-GP LLC 10% Owner | 992,305 | $0 | 1,233,615 (Indirect) | View |
| 2022-06-06 Other | 2022-06-07 4:36 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Versant Ventures V LLC Versant Ophthalmic Affiliates I L.P. Versant Affiliates Fund V L.P. Versant Venture Capital V (Canada) LP Versant Ventures V GP-GP (Canada) Inc. Versant Venture Capital V L.P. Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Ventures V (Canada) L.P. 10% Owner | 992,305 | $0 | 1,233,615 (Indirect) | View |
| 2022-06-06 Other | 2022-06-07 4:32 pm | N/A N/A | Repare Therapeutics Inc. | RPTX | Jerel Davis Director 10% Owner | 1,001,406 | $0 | 1,263,593 (Indirect) | View |
| 2022-05-13 Option Award | 2022-05-16 7:31 pm | N/A 2032-05-13 | Repare Therapeutics Inc. | RPTX | SCHAFER CAROL Director | 49,000 | $0 | 49,000 (Direct) | View |